These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 29359980

  • 1. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
    Jung S, Bohan A.
    Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
    [Abstract] [Full Text] [Related]

  • 2. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
    Li Q, Freeman LM, Rush JE, Laflamme DP.
    Int J Mol Sci; 2015 Jun 19; 16(6):14098-108. PubMed ID: 26101868
    [Abstract] [Full Text] [Related]

  • 3. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS, Häggström J, Pedersen HD, Hansson K, Järvinen AK, Haukka J, Kvart C.
    J Vet Cardiol; 2014 Sep 19; 16(3):141-54. PubMed ID: 25130405
    [Abstract] [Full Text] [Related]

  • 4. Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.
    Yang VK, Loughran KA, Meola DM, Juhr CM, Thane KE, Davis AM, Hoffman AM.
    J Extracell Vesicles; 2017 Sep 19; 6(1):1350088. PubMed ID: 28804599
    [Abstract] [Full Text] [Related]

  • 5. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Cremer SE, Kristensen AT, Reimann MJ, Eriksen NB, Petersen SF, Marschner CB, Tarnow I, Oyama MA, Olsen LH.
    Am J Vet Res; 2015 Jun 19; 76(6):520-31. PubMed ID: 26000599
    [Abstract] [Full Text] [Related]

  • 6. Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure.
    Jung SW, Sun W, Griffiths LG, Kittleson MD.
    J Vet Intern Med; 2016 Jun 19; 30(1):51-7. PubMed ID: 26681398
    [Abstract] [Full Text] [Related]

  • 7. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH.
    Vet J; 2016 Mar 19; 209():113-8. PubMed ID: 26831162
    [Abstract] [Full Text] [Related]

  • 8. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S.
    Vet J; 2020 Sep 19; 263():105518. PubMed ID: 32928487
    [Abstract] [Full Text] [Related]

  • 9. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
    Falk T, Ljungvall I, Zois NE, Höglund K, Olsen LH, Pedersen HD, Häggström J.
    J Vet Intern Med; 2013 Sep 19; 27(3):500-6. PubMed ID: 23551840
    [Abstract] [Full Text] [Related]

  • 10. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Sep 19; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 11. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
    Reimann MJ, Häggström J, Møller JE, Lykkesfeldt J, Falk T, Olsen LH.
    J Vet Intern Med; 2017 Mar 19; 31(2):295-302. PubMed ID: 28132441
    [Abstract] [Full Text] [Related]

  • 12. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 19; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C, Guglielmini C, Domenech O, Contiero B, Zini E, Poser H.
    PLoS One; 2020 Jun 19; 15(9):e0238440. PubMed ID: 32870923
    [Abstract] [Full Text] [Related]

  • 17. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN, Christopher Orton E, Boon J, Nishimori CT, Olivaes C, Camacho AA.
    J Vet Cardiol; 2011 Sep 19; 13(3):197-201. PubMed ID: 21824833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.